1274 related articles for article (PubMed ID: 6252299)
21. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
[No Abstract] [Full Text] [Related]
22. [Bone scintigraphy with 99mTc-hydroxymethylene diphosphonate (HMDP)--comparison with 99mtc-MDP (author's transl)].
Nakano S; Hasegawa Y; Shiomura K; Ibuka K; Hashizume T
Kaku Igaku; 1981 Dec; 18(10):1485-8. PubMed ID: 6210789
[No Abstract] [Full Text] [Related]
23. [Diagnosis of acute myocardial infarction with 99mTc-hydroxymethylene diphosphonate (HMDP)].
Miyao K; Takahashi T; Kusuoka S; Kubota Y; Tanimura C; Mineo T; Ohmura M; Taniike K; Yamada C; Nakagawa H
Kaku Igaku; 1984 Feb; 21(2):117-24. PubMed ID: 6471588
[No Abstract] [Full Text] [Related]
24. Bone-seeking properties of Tc-99m carbonyl diphosphonic acid, dihydroxy-methylene diphosphonic acid and monohydroxy-methylene phosphoinic acid: concise communication.
Wang TS; Fawwaz RA; Johnson LJ; Mojdehi GE; Johnson PM
J Nucl Med; 1980 Aug; 21(8):767-70. PubMed ID: 7400832
[TBL] [Abstract][Full Text] [Related]
25. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
Silberstein EB
Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
[TBL] [Abstract][Full Text] [Related]
26. [Clinical evaluation of 99mTc-hydroxymethylene diphosphonate (HMDP) bone scintigraphy: comparison with 99mTc-MDP (author's transl)].
Honda H; Oshiumi Y; Kamoi I; Ichiya Y; Wada M; Matsuura K
Kaku Igaku; 1981 Nov; 18(9):1315-9. PubMed ID: 6461790
[No Abstract] [Full Text] [Related]
27. Myocardial infarct imaging: superiority of inorganic agents over organic diphosphonates.
Logic JR; Meyer-Pavel CM; Blackman J
J Nucl Med; 1981 Jul; 22(7):659-70. PubMed ID: 6265610
[No Abstract] [Full Text] [Related]
28. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: concise communication.
Van Duzee BF; Schaefer JA; Ball JD; Chilton HM; Cowan RJ; Kuni C; Trow R; Watson NE
J Nucl Med; 1984 Feb; 25(2):166-9. PubMed ID: 6233404
[TBL] [Abstract][Full Text] [Related]
29. A study of the relationship between chemical structure and bone localization of Tc-99m diphosphonic acids: concise communication.
Wang TS; Mojdehi GE; Fawwaz RA; Johnson PM
J Nucl Med; 1979 Oct; 20(10):1066-70. PubMed ID: 536757
[TBL] [Abstract][Full Text] [Related]
30. Early-phase myocardial uptake intensity of
Abulizi M; Cottereau AS; Guellich A; Vandeventer S; Galat A; Van Der Gucht A; Plante-Bordeneuve V; Dubois-Randé JL; Bodez D; Rosso J; Damy T; Itti E
J Nucl Cardiol; 2018 Feb; 25(1):217-222. PubMed ID: 27804073
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Tc-99m methylene diphosphonate with Tc-99m pyrophosphate in the detection of acute myocardial infarction: concise communication.
Singh A; Usher M
J Nucl Med; 1977 Aug; 18(8):790-2. PubMed ID: 194934
[TBL] [Abstract][Full Text] [Related]
32. Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
Godart G; Durez M; Bevilacqua M; Abramovici J; Robience Y
Clin Nucl Med; 1986 Feb; 11(2):92-7. PubMed ID: 3769350
[TBL] [Abstract][Full Text] [Related]
33. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
[No Abstract] [Full Text] [Related]
34. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
Atamaniuk NP; Mechev DS
Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
[TBL] [Abstract][Full Text] [Related]
35. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
36. Tc-99m methylene diphosphonate versus Tc-99m pyrophosphate: biologic and clinical comparison.
Rudd TG; Allen DR; Hartnett DE
J Nucl Med; 1977 Sep; 18(9):872-6. PubMed ID: 197133
[TBL] [Abstract][Full Text] [Related]
37. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
[TBL] [Abstract][Full Text] [Related]
38. 99mTc-aminohexylidendiphosphonate and 99mTc-pyrophosphate in the scintigraphic diagnosis of experimental myocardial infarction in dogs.
Duska F; Hadas L; Vizda J; Kafka P; Urbanová E; Palicka V; Mazurová Y; Kuba M; Grossman V
Nuklearmedizin; 1988 Oct; 27(5):226-7. PubMed ID: 2848225
[TBL] [Abstract][Full Text] [Related]
39. A comparison of technetium etidronate and pyrophosphate for acute myocardial infarct imaging.
Williams CC; Nishiyama H; Adolph RJ; Romhilt DW; Sodd VJ; Saenger EL; Gabel M
J Nucl Med; 1977 Sep; 18(9):905-9. PubMed ID: 197134
[TBL] [Abstract][Full Text] [Related]
40. A crossover study comparing Tc-99m-labeled HMDP and MDP in patients.
Rosenthall L; Arzoumanian A; Damtew BU; Tremblay J
Clin Nucl Med; 1981 Aug; 6(8):353-5. PubMed ID: 6455231
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
